Replies to post #256504 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Top-line results from the Anavex PDD trial should be very easy and quick to analyze using computerized statistical analysis programs that are commercially available.

Below is the list of endpoints for the trial to determine the top-line results:

Outcome Measures:


Primary Outcome Measures:
Cognitive Drug Research (CDR) Computerized Assessment System Continuity of Attention [ Time Frame: 14 weeks ]
Change from Baseline to End of Treatment in Continuity of Attention as measured by Cognitive Drug Research (CDR) Computerized Assessment System Continuity of Attention test

Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 [ Time Frame: 14 weeks ]
Assess the safety and tolerability of ANAVEX2-73 compared to placebo


Secondary Outcome Measures:
MDS-UPDRS Part III Total Score (Motor Scores) [ Time Frame: 14 weeks ]
Change from baseline to End of Treatment as measured by MDS-UPDRS Part III Total Score (Motor Scores)

SDS-CL-25 [ Time Frame: 14 weeks ]
Incidence of sleep disorders symptoms (SDS-CL-25)

https://clinicaltrials.gov/ct2/show/NCT03774459

Good luck and GOD bless,

[raja48185]

Since we know that the clinical data has been locked, then we also know that the top-line results will be available for a press release SOON!!!

How SOON???

May be they skip the Top-line results and present the final data (especially if the Top-Line data turns out to be 'Top-Shelf').

In My Useless Opinion.